Back to GI Giverny Capital Inc.

EW

23 quarters

Position history for GIGiverny Capital Inc.'s holdings in Edwards Lifesciences Corporation

No. Giverny Capital exited its EW (Edwards Lifesciences) position in Q1 2025. Its Q4 2024 13F listed 257 shares worth $19,026. Giverny Capital already held EW in its Q3 2019 13F, the earliest on record, and held it in 22 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$28M

Total Shares Change

-127,233

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$72.48
0
2024-Q4
Decreased
257
-99.9%
$19,0260.0%$74.03
0
2024-Q3
Increased
446,288
+0.1%
$29.5M1.1%$65.99
45
2024-Q2
Increased
446,016
+0.1%
$41.2M1.7%$92.37
47
2024-Q1
Increased
445,718
+1.1%
$42.6M1.7%$95.56
46
2023-Q4
Increased
440,906
+0.1%
$33.6M1.6%$76.25
45
2023-Q3
Increased
440,602
+0.2%
$30.5M1.7%$69.28
45
2023-Q2
Increased
439,896
+6.0%
$41.5M2.2%$94.33
53
2023-Q1
Decreased
414,975
-2.6%
$34.3M2.1%$82.73
0
2022-Q4
Decreased
426,173
-0.9%
$31.8M2.0%$74.61
0
2022-Q3
Increased
430,196
+3.2%
$35.5M2.4%$82.63
51
2022-Q2
Increased
416,882
+2.9%
$39.6M2.6%$95.09
51
2022-Q1
Decreased
405,091
-0.2%
$47.7M2.7%$117.72
0
2021-Q4
Increased
405,762
+0.9%
$52.6M2.8%$129.55
51
2021-Q3
Decreased
402,150
-0.8%
$45.5M2.7%$113.21
0
2021-Q2
Increased
405,529
+3.9%
$42M2.6%$103.57
52
2021-Q1
Increased
390,140
+0.6%
$32.6M2.2%$83.64
50
2020-Q4
Increased
387,814
+3.9%
$35.4M2.7%$91.23
52
2020-Q3
Increased
373,422
+0.2%
$29.8M2.7%$79.82
49
2020-Q2
Increased
372,627
+4.9%
$25.8M2.6%$69.11
53
2020-Q1
Decreased
118,426
-7.8%
$22.3M2.8%$62.87
0
2019-Q4
Increased
128,515
+1.0%
$30M2.7%$77.76
51
2019-Q3
First report
127,233
-
$28M2.8%$73.30
0

Other major holders of EW: Vanguard Group Inc., BlackRock, Inc.

Optional analytics helps us improve. How it’s used